NBT Bank’s West Pharmaceutical WST Stock Holding History

NBT Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5	Closed	-$1.8K	–	1028
2026 Q2	$1.8K	Hold	5	–	–	﹤0.01%	886
2026 Q1	$1.25K	Buy	+5	New	+$1.24K	﹤0.01%	902

Other funds holding WST

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

NBT Bank's WST Position: Q3 2026 in Review

NBT Bank sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 5 shares — an estimated $1.8K sold.

NBT Bank first reported a position in WST in Q1 2026 and held it in 2 quarters. The position peaked at $1.8K in Q2 2026. 530 funds tracked by Wall St. Rank hold WST as of Q3 2026.

NBT Bank reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
NBT Bank sold 5 West Pharmaceutical shares in Q3 2026, an estimated $1.8K.
NBT Bank first reported a position in West Pharmaceutical in Q1 2026 and held it in 2 quarters.
NBT Bank's West Pharmaceutical position peaked at $1.8K in Q2 2026.
530 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on NBT Bank's 13F filing for Q3 2026, filed 21 Oct 2026.